Literature DB >> 36116839

Persistent Symptoms After Treatment of Lyme Disease.

Adriana Marques1.   

Abstract

Most patients with Lyme disease will fully recover with recommended antibiotic therapy. However, some patients report persisting nonspecific symptoms after treatment, referred to as posttreatment Lyme disease symptoms (PTLDs) or syndrome (PTLDS), depending on the degree to which the individual's symptoms impact their quality of life. PTLDs occur in a portion of patients diagnosed with chronic Lyme disease (CLD), a controversial term describing different patient populations, diagnosed based on unvalidated tests and criteria. Practitioners should review the evidence for the Lyme disease diagnosis and not overlook unrelated conditions. Current evidence shows that prolonged antibiotic therapy provides little benefit and carries significant risk. Further research to elucidate the mechanisms underlying persistent symptoms after Lyme disease and to understand CLD is needed. Published by Elsevier Inc.

Entities:  

Keywords:  Chronic Lyme disease; Long-term symptoms; Lyme disease; Misdiagnosis; Posttreatment Lyme disease syndrome

Mesh:

Substances:

Year:  2022        PMID: 36116839      PMCID: PMC9494579          DOI: 10.1016/j.idc.2022.04.004

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.905


  122 in total

Review 1.  A critical appraisal of "chronic Lyme disease".

Authors:  Henry M Feder; Barbara J B Johnson; Susan O'Connell; Eugene D Shapiro; Allen C Steere; Gary P Wormser; W A Agger; H Artsob; P Auwaerter; J S Dumler; J S Bakken; L K Bockenstedt; J Green; R J Dattwyler; J Munoz; R B Nadelman; I Schwartz; T Draper; E McSweegan; J J Halperin; M S Klempner; P J Krause; P Mead; M Morshed; R Porwancher; J D Radolf; R P Smith; S Sood; A Weinstein; S J Wong; L Zemel
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

2.  Neoplasms misdiagnosed as "chronic lyme disease".

Authors:  Christina Nelson; Sarah Elmendorf; Paul Mead
Journal:  JAMA Intern Med       Date:  2015-01       Impact factor: 21.873

3.  Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.

Authors:  Robert P Smith; Robert T Schoen; Daniel W Rahn; Vijay K Sikand; John Nowakowski; Dennis L Parenti; Mary S Holman; David H Persing; Allen C Steere
Journal:  Ann Intern Med       Date:  2002-03-19       Impact factor: 25.391

4.  Azithromycin Is Equally Effective as Amoxicillin in Children with Solitary Erythema Migrans.

Authors:  Maja Arnež; Eva Ružić-Sabljić
Journal:  Pediatr Infect Dis J       Date:  2015-10       Impact factor: 2.129

5.  Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.

Authors:  Anneleen Berende; Hadewych J M ter Hofstede; Fidel J Vos; Henriët van Middendorp; Michiel L Vogelaar; Mirjam Tromp; Frank H van den Hoogen; A Rogier T Donders; Andrea W M Evers; Bart Jan Kullberg
Journal:  N Engl J Med       Date:  2016-03-31       Impact factor: 91.245

6.  The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study.

Authors:  M C Reid; R T Schoen; J Evans; J C Rosenberg; R I Horwitz
Journal:  Ann Intern Med       Date:  1998-03-01       Impact factor: 25.391

7.  Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome.

Authors:  Barbro Hedin Skogman; Stefan Croner; Maria Nordwall; Mattias Eknefelt; Jan Ernerudh; Pia Forsberg
Journal:  Pediatr Infect Dis J       Date:  2008-12       Impact factor: 2.129

8.  Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course.

Authors:  Kristine Mørch; Kurt Hanevik; Ann C Rivenes; Jørn E Bødtker; Halvor Næss; Bjarte Stubhaug; Knut-Arne Wensaas; Guri Rortveit; Geir E Eide; Trygve Hausken; Nina Langeland
Journal:  BMC Gastroenterol       Date:  2013-02-12       Impact factor: 3.067

9.  Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis.

Authors:  Brandon L Jutras; Robert B Lochhead; Zachary A Kloos; Jacob Biboy; Klemen Strle; Carmen J Booth; Sander K Govers; Joe Gray; Peter Schumann; Waldemar Vollmer; Linda K Bockenstedt; Allen C Steere; Christine Jacobs-Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-17       Impact factor: 11.205

10.  Predicting Lyme Disease From Patients' Peripheral Blood Mononuclear Cells Profiled With RNA-Sequencing.

Authors:  Daniel J B Clarke; Alison W Rebman; Allison Bailey; Megan L Wojciechowicz; Sherry L Jenkins; John E Evangelista; Matteo Danieletto; Jinshui Fan; Mark W Eshoo; Michael R Mosel; William Robinson; Nitya Ramadoss; Jason Bobe; Mark J Soloski; John N Aucott; Avi Ma'ayan
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.